Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Fludarabine

    ... The U.S. Food and Drug Administration (FDA) approved fludarabine for treating chronic lymphocytic leukemia (CCL). Researchers are studying fludarabine in combination with other medicines for treating bone marrow ...

    Drug last updated 03/24/2016 - 12:32pm.

  2. Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.

    ... (HSCT) with a conditioning regimen consisting of fludarabine (F-araA) and cyclophosphamide (Cy) is associated with ...

    Research Article last updated 05/22/2017 - 10:32am.

  3. Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia

    ... regimen before HSCT included cyclophosphamide , fludarabine , pig anti-human lymphocyte immune globulin (p-ALG) ...

    Research Article last updated 02/03/2017 - 9:36am.

  4. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia

    ... regimen consisted of antithymocyte globulin , fludarabine , low-dose cyclophosphamide, and total body irradiation. ...

    Research Article last updated 01/24/2017 - 10:04am.

  5. Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

    ... is not a widely accepted first-line treatment. Recently, fludarabine , lower-dose cyclophosphamide and antithymocyte ...

    Research Article last updated 11/28/2016 - 9:28am.

  6. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia

    ... preconditioning regimen included reduced-strength fludarabine combined with Busulfex and cytarabine, cyclophosphamide. ...

    Research Article last updated 11/01/2016 - 1:59pm.

  7. A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia

    ... of reduced-dose cyclophosphamide (CY) and fludarabine (FDR) have been investigated for use in allogeneic ...

    Research Article last updated 03/06/2014 - 11:00am.

  8. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.

    ... cyclophosphamide (Cy, 25 mg/kg for four days), fludarabine (Flu, 30 mg/m2 for four days), and rabbit ATG (2.5 mg/kg for ...

    Research Article last updated 05/14/2013 - 1:00pm.

  9. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.

    ... comprising reduced cyclophosphamide (Cy), fludarabine , and anti-thymocyte globulin (ATG) (Cy-Flu-ATG) was used to ... Cy at 200 mg/kg. Those in the Cy-Flu-ATG arm received fludarabine (Flu) at 150 mg/m(2) and Cy at 100 mg/kg. A total of 83 patients ...

    Research Article last updated 05/11/2012 - 2:04pm.

  10. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party.

    ... regimen, patients received either a combination of fludarabine , cyclophosphamide , and antithymocyte globulin ... 5-year survival was 73% for the group that received fludarabine, cyclophosphamide, and antithymocyte globulin and 79% for the ...

    Research Article last updated 10/11/2011 - 5:58pm.